Last reviewed · How we verify

NCT06133803

Lovenox With Aspirin in Thawed Blastocyst Transfer

Status unknown Phase 4 Last updated 21 February 2024
What this trial tests

Phase 4 trial testing Lovenox in Infertility, Female in 130 participants. Status unknown.

Timeline
26 January 2024
Primary endpoint
15 December 2024
15 December 2024

Quick facts

Lead sponsorFertility Center of Las Vegas
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment130
Start date26 January 2024
Primary completion15 December 2024
Estimated completion15 December 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Fertility Center of Las Vegas — full company profile →

Who can join

Adults 18 to 42, female only, with Infertility, Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective randomized trial will compare outcomes in patients receiving aspirin in combination with a low-molecular weight heparin and those under this center's standard protocol receiving neither medication, in order to determine if these medications may improve success rates.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lovenox

Trials testing the same drug.

Other recruiting trials for Infertility, Female

Currently open trials in the same condition.

Other Fertility Center of Las Vegas trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06133803.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing